ACTIVE

Lansinoh Laboratories Benelux

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result472,7 k €+144,0 %over 1 year

Gross margin887,5 k €+51,2 %over 1 year

Equity1,6 M €-31,5 %over 1 year

Workforce2,9 ETP-3,3 %over 1 year

Identity

Source · BCE/KBO

Lansinoh Laboratories Benelux is a Public limited company incorporated in 2015. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Herentals. It employs on average 2,9 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0630.939.468
Incorporation: 29/05/2015
Legal form: Public limited company
Registered office: Diamantstraat (HRT) 8 box 383
2200 Herentals · FlandreSee on map
Contributed capital: 62 000,00 €
Latest accounts: 31/12/2025
Average workforce: 2,9 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 33190Repair of other equipment 33190Repair of other equipment 47740Retail sale of medical and orthopaedic goods in specialised stores 47741Retail sale of medical and orthopaedic goods in specialised stores+2

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 10 filings

Trend over 10 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	887,5 k €	+51.2%	587,1 k €	+41.2%	415,8 k €	-11.8%	471,3 k €	-63.5%	1,3 M €
EBITDA	661,6 k €	+82.5%	362,6 k €	+61.3%	224,8 k €	-24.2%	296,8 k €	-35.2%	458,3 k €
Operating result	641 k €	+114%	299 k €	+42.7%	209,5 k €	-17.8%	254,7 k €	-36.2%	399,4 k €
Net result	472,7 k €	+144%	193,7 k €	+22.0%	158,8 k €	+19.6%	132,7 k €	-44.7%	239,8 k €
Balance sheet
Equity	1,6 M €	-31.5%	2,3 M €	+9.2%	2,1 M €	+8.1%	2 M €	+7.3%	1,8 M €
Total assets	3,1 M €	+20.2%	2,6 M €	+0.5%	2,6 M €	-8.4%	2,8 M €	+10.4%	2,5 M €
Cash	1,9 M €	+105%	911,2 k €	+50.8%	604,3 k €	+30.9%	461,5 k €	-49.4%	911,3 k €
Debts	1,5 M €	+473%	263,1 k €	-41.3%	448,4 k €	-46.9%	844,4 k €	+24.0%	681 k €
Other
Workforce	2,9 ETP	-3.3%	3,0 ETP	+7.1%	2,8 ETP	+21.7%	2,3 ETP	-77.7%	10,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 15 ended

Active mandates

Julie Talbot

Director · since 27 mars 2026

Active

Kevin Vyse-Peacock

Director · since 12 juillet 2024 · until 27 mars 2026

Active

Vanessa Cook

Managing director · since 12 juillet 2024 · until 30 mai 2031

Active

Ended mandates

Kevin Vyse-Peacock

Director · since 12 juillet 2024 · until 12 juillet 2030

Ended

Vanessa Cook

Director · since 12 juillet 2024 · until 12 juillet 2030

Ended

KEVIN VYSE - PEACOCK

Managing director · since 03 septembre 2021 · until 03 septembre 2027

Ended

Kevin VYSE-PEACOCK

Director · since 03 septembre 2021 · until 03 septembre 2027

Ended

Other companies at this address

Diamantstraat (HRT) 8 2200 Herentals

Company	CBE no.
212 Degrees● Active	1039.552.265
ABW CONSULTING● Active	1007.238.991
ACCESS KING● Active	0847.621.533
Ace Of Actions● Active	1041.194.238
ACG²● Active	1033.636.948
AEP SOLAR 21● Active	0753.734.738
AG HEYLEN WAREHOUSES● Active	0633.928.058
Aluminium op Maat gemaakt● Active	0629.766.461
ALUNA WEST-EUROPE● Active	0890.382.497
Ambulancedienst Turnhout E.H.B.O.● Active	0419.498.175
ANTWERP EAST PORTSIDE 21● Active	0535.768.216
ASDP● Bankrupt	0740.843.834
Ashanti Group● Bankrupt	0635.520.244
AUXILIUM QUERCO● Active	0685.498.604
AVEST PROJECTONTWIKKELING● Bankrupt	0538.596.755
AZK● Active	1018.977.377
Azzura● Active	1023.419.878
BAKER & STANLEY● Active	0880.602.424
BALASEC SOLUTIONS● Active	0777.260.802
Basecamp België● Active	0836.741.893

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	17/06/2026	02/07/2025	15/07/2024	27/07/2023	21/09/2022	08/07/2021
General meeting	15/06/2026	30/06/2025	12/07/2024	24/07/2023	16/09/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 10 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	15/06/2026	17/06/2026	Dutch	PDF
Abridged model	31/12/2024	30/06/2025	02/07/2025	Dutch	PDF
Abridged model	31/12/2023	12/07/2024	15/07/2024	Dutch	PDF
Abridged model	31/12/2022	24/07/2023	27/07/2023	Dutch	PDF
Abridged model	31/12/2021	16/09/2022	21/09/2022	Dutch	PDF
Abridged model	31/12/2020	30/06/2021	08/07/2021	Dutch	PDF
Abridged model	31/12/2019	30/06/2020	10/07/2020	Dutch	PDF
Abridged model	31/12/2018	22/07/2019	31/07/2019	Dutch	PDF
Abridged model	31/12/2017	30/06/2018	09/08/2018	Dutch	PDF
Abridged model	31/12/2016	26/05/2017	31/07/2017	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 15 ended

Active mandates

Julie Talbot

Director · since 27 mars 2026

Active

Kevin Vyse-Peacock

Director · since 12 juillet 2024 · until 27 mars 2026

Active

Vanessa Cook

Managing director · since 12 juillet 2024 · until 30 mai 2031

Active

Ended mandates

Kevin Vyse-Peacock

Director · since 12 juillet 2024 · until 12 juillet 2030

Ended

Vanessa Cook

Director · since 12 juillet 2024 · until 12 juillet 2030

Ended

KEVIN VYSE - PEACOCK

Managing director · since 03 septembre 2021 · until 03 septembre 2027

Ended

Kevin VYSE-PEACOCK

Director · since 03 septembre 2021 · until 03 septembre 2027

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates12/08/2026
Benoemingen - Ontslagen
PDF
Mandates05/05/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/08/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/01/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
PDF
Registered office17/12/2024
MAATSCHAPPELIJKE ZETEL
PDF
Mandates22/10/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/12/2018
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/01/2018
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025472,7 k €↑
2024
Annual accounts 2024193,7 k €↑
2023
Annual accounts 2023158,8 k €↑
2022
Annual accounts 2022132,7 k €↓
2021
Annual accounts 2021239,8 k €↓
2020
Annual accounts 2020263,2 k €↓
2019
Annual accounts 2019319,4 k €↓
2018
Annual accounts 2018506,5 k €↑
2017
Annual accounts 2017246,9 k €↑
2016
Annual accounts 2016185,1 k €
29/05/2015
IncorporationPublic limited company

Lansinoh Laboratories Benelux

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline